Abstract: Battery management systems (BMS) are widely used for proper protection and utilization of battery systems. In this paper, a modular BMS circuit is proposed for the design of modular battery ...

Huzhou FFD Power will localize BMS, EMS, and C&I BESS cabinet production in Europe; initial cabinet platforms: 261 ...

BMS achieved non-GAAP EPS of $6.15 for the full year, a substantial improvement from $1.15 in 2024. Credit: Piotr Swat / Shutterstock.com. Bristol Myers Squibb (BMS) has reported full-year 2025 ...

Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...

Bristol Myers Squibb and Johnson & Johnson have said they will stop development of their oral Factor XIa inhibitor milvexian in acute coronary syndrome after a disappointing trial result. The decision ...

Bristol Myers Squibb delivered better than expected fourth quarter earnings, but Eliquis missed expectations while Cobenfy continues to struggle with uptake. Bristol Myers Squibb sales hit $12.5 ...

Bristol Myers Squibb is partnering up with Evinova’s AI clinical development platform across the Big Pharma company’s global portfolio in an effort to improve efficiency and cut costs. The agreement ...

Bayer has linked asundexian to a 26% reduction in stroke in a phase 3 study, setting the bar for Bristol Myers Squibb and Johnson & Johnson’s rival factor XIa inhibitor in a blockbuster indication.

Lithium batteries power an expanding range of technologies, from electric vehicles and commercial transportation fleets to stationary energy storage systems and grid-scale backup power installations.

Bristol Myers Squibb is leaning heavily on its newer key products, grouped into its growth portfolio category, to weather the storm it expects as it heads toward further declines within its legacy ...